Real World Data Guidelines - Current Status Review
暂无分享,去创建一个
[1] Andrea Manca,et al. NICE DSU TECHNICAL SUPPORT DOCUMENT 17: THE USE OF OBSERVATIONAL DATA TO INFORM ESTIMATES OF TREATMENT EFFECTIVENESS IN TECHNOLOGY APPRAISAL: METHODS FOR COMPARATIVE INDIVIDUAL PATIENT DATA , 2015 .
[2] J. Hay. Health care costs and outcomes: how should we evaluate real world data? , 1999, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[3] R. Willke,et al. “Ten Commandments” for Conducting Comparative Effectiveness Research Using “Real-World Data” , 2011, Journal of managed care pharmacy : JMCP.
[4] Mike Thomas,et al. Quality standards for real-world research. Focus on observational database studies of comparative effectiveness. , 2014, Annals of the American Thoracic Society.
[5] Douglas G Altman,et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2008, BMJ.
[6] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.
[7] L. Garrison,et al. Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.